Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuri is an active space biotechnology company specializing in leveraging microgravity environments—primarily on the International Space Station (ISS) and other spacecraft—to enable advanced biotechnological research and product development. Their modular bioreactors and incubators support cell cultures, protein crystals, plant growth, drug discovery efforts, optimized biomaterials development, and sustainable food production. They have completed over 151 space lab launches for more than 60 customers across four continents. Notable partnerships include NASA, ESA, GSK, Charité Berlin, MIT; they have generated over €10 million in revenue from contracts[4][3][1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuri.